Profil
John McCabe's current job(s) include being the Chief Operating Officer at Longwood Fund Management LLC since 2022 and the Chief Financial Officer/Chief Operating Officer at DEM BioPharma, Inc. since 2022.
Mr. McCabe's former job(s) include being the Director-Strategic Business Unit Controller at Biogen, Inc. from 2007 to 2009, the Chief Accounting Officer & Vice President at ARIAD Pharmaceuticals, Inc. in 2013, the Chief Financial Officer, Secretary & Treasurer at Flex Pharma, Inc. from 2014 to 2019, the Audit Manager at Arthur Andersen LLP from 1991 to 2000, and the Vice President & Controller at Charles River Associates (Asia Pacific) Ltd. from 2009 to 2013.
Mr. McCabe's education history includes an undergraduate degree from Babson College in 1991 and an MBA from the University of Massachusetts in 2009.
Postes actifs de John McCabe
| Sociétés | Poste | Début |
|---|---|---|
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Private Equity Investor | 01/04/2022 |
DEM BioPharma, Inc.
DEM BioPharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that manufactures cancer therapeutics | Directeur Financier/CFO | 01/04/2022 |
Anciens postes connus de John McCabe
| Sociétés | Poste | Fin |
|---|---|---|
| ONCORUS, INC. | Directeur Financier/CFO | 01/04/2022 |
Flex Pharma, Inc.
Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Directeur Financier/CFO | 01/07/2019 |
| ARIAD PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/05/2014 |
Charles River Associates (Asia Pacific) Ltd.
Charles River Associates (Asia Pacific) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides economic, financial, and management consulting services | Comptroller/Controller/Auditor | 01/05/2013 |
| BIOGEN INC. | Corporate Officer/Principal | 01/06/2009 |
Formation de John McCabe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Flex Pharma, Inc.
Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Health Technology |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Babson College
Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Charles River Associates (Asia Pacific) Ltd.
Charles River Associates (Asia Pacific) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides economic, financial, and management consulting services | Commercial Services |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
Oncorus, Inc.
Oncorus, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops next generation immunotherapy platform to treat cancer | Health Technology |
DEM BioPharma, Inc.
DEM BioPharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that manufactures cancer therapeutics | Commercial Services |
















